Gland Pharma files DRHP with SEBI
The Initial Public Offer (IPO) comprises of a fresh issue aggregating up to Rs. 12,500 million (the “Fresh Issue”) and an offer…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
No compromise on rigorous evaluation for vaccine candidates: Scientific Advisor VijayRaghavan
India's drug regulator has given the go-ahead for trials for two vaccine candidates -- Bharat Biotech vaccine and the Zydus Cadila…
EMA finalises opinion on presence of nitrosamines in medicines
Companies will be required to have appropriate control strategies to prevent or limit the presence of these impurities and, where…
Luca Galluzzi to succeed Peter Gucher as Chief Sales Officer at B&R
In addition to his position on the executive management team, Galluzzi will retain his current responsibilities as Managing…
DCGI approves Itolizumab for restricted emergency use in COVID-19 treatment
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by an expert committee,…
Pharma industry deny allegations of GST evasion on hand sanitisers
Industry associations have made representation to different government authorities seeking more clarity
Cadila Pharma launches esomeprazole tablets in India
It will be marketed under brand name Esiloc in India for treatment of hyperacidity and drug induced gastritis
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
Pankajakasthuri announces promising interim results for ZingiVir–H among COVID-19 patients
ZingiVir-H is a herbo-mineral drug made of a blend of seven ingredients
Mylan and Pfizer’s Upjohn unveil logo and branding for Viatris
Announcement follows Mylan shareholder approval of Mylan’s combination with Pfizer’s Upjohn. Viatris is a new company that will be…
Gujarat government to procure 20,000 vials of remdesivir
The state government has already placed a bulk order for 8000 tocilizumab injections with Cipla
Cipla continues to expand focus on therapy areas of promising growth through deals: GlobalData
In recent years, Cipla also had agreements with Roche India, Mannkind USA, Stempeutics Research, Novartis and Luye Pharma to…
International regulators align positions on phase 3 COVID-19 vaccine trials
The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those…
Panacea Biotec aims to make 1-bn doses of COVID-19 vaccine candidate in 2022
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration…
EU raises its bet on blood plasma in search for COVID-19 therapy
The move also highlights the more assertive approach being taken by the 27-nation union in the race to find effective drugs and…
Lupin recalls diabetes treatment drug in US
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg…
Moderna signs deal with Spain’s Rovi to supply potential COVID-19 vaccine outside US
Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies…
Strides receives USFDA approval for headache drug
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules will be marketed by Strides Pharma in the US market
Future proofing of work function will be defined by a maturity model across three elements: IPA-BCG
In an article, ‘Future of Work: Building the future quality function’, the Indian Pharmaceutical Alliance (IPA) and Boston…
Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval
The drug, aducanumab, has had a tumultuous journey, with promising early data raising hopes and Biogen’s share price, only to be…